Neonatal intensive care unit; Pulsed-field gel electrophoresis (PFGE); Serratia marcescens Background: Serratia marcescens is a well-known but relatively uncommon cause of nosocomial infections, particularly in neonatal intensive care unit (NICU) patients. We investigated an outbreak of S marcescens in the NICU at the Farabi Hospital of Karadeniz Technical University in Trabzon, Turkey. Methods: Between March 21 and May 27, 2006, nine of the neonates were identified with cultures of S marcescens, and there were three deaths because of septicemia. For the purpose of identifying the source of infection, 85 environmental samples, two breast milk samples from two babies' mothers, and 38 hand-washing samples from the health care workers (HCWs) were collected for the detection of S marcescens. All the S marcescens isolates were genotyped by pulsed-field gel electrophoresis with endonuclease SpeI restriction enzyme. Results: Serratia marcescens was identified from one hand-washing sample and two breast milk samples. None of the environmental samples yielded S marcescens. Of the 13 isolates analyzed, four belonged to one major genotype, whereas eight (6 from neonates and 2 from breast milk) were indistinguishable; two isolates (2 from neonates) were closely related; and three isolates (2 other neonates and 1 from HCW's hand) were different. Our intensive efforts failed to determine the source of the outbreak despite the finding that S marcescens strain was isolated from a HCW's hand. Conclusion: Present investigation suggested that an outbreak of S marcescens infection was caused by a major clone in our NICU, possibly transmitted through the hands of HCWs,
Introduction
Serratia is a genus of gram-negative rod belonging to the Enterobacteriaceae family. Serratia marcescens is the species of Serratia most commonly isolated from human infections. 1 Serratia marcescens, although initially thought to be nonpathogenic and relatively uncommon in the health care system, appears to emerge as a cause of serious nosocomial infections, especially in neonatal intensive care units (NICUs). 2, 3 Urinary tract infections are not uncommon, followed by pneumonias and skin and soft tissue infections. 1 Management of S marcescens-associated infection is problematic because many strains of the bacterium manifest resistance to multiple antibiotics, including b-lactams, aminoglycosides, and quinolones. 1, 4 Therefore, it is important to identify the sources of the outbreak for better management of the spread of the organism. In our NICU, an increase in the number of cases of S marcescens was observed over the past few months, and thus, an epidemiologic investigation was launched on the clinical features of a S marcescens outbreak in the NICU with a view to prevent further cases.
Methods Background
The study was carried out in a 720-bed, tertiary care, teaching hospital of Farabi in Trabzon, Turkey. The NICU has 20 beds admitting critically ill neonates. The unit admits between 500 and 600 patients annually. Three sinks with sensor-operated automatic faucets are available in the NICU, and gloves are used routinely. Hand disinfectants containing alcohol are kept near each bed. Active surveillance for nosocomial infections are performed by the infection control nurses and infectious-disease specialists, using the criteria proposed by the Centers for Disease Control and Prevention and National Nosocomial Infections Surveillance System methodology.
Between March 21 and May 27, 2006, an increase in the number of cases of S marcescens infection was observed in the NICU; nine neonates became infected and one was identified to be colonized with S marcescens, three of whom died with septicemia (Table 1) . Seven of these neonates were born prematurely.
The study was initiated when a female infant was found to have S marcescens sepsis and died on March 23, 2006. She (gestational week 40) was delivered vaginally in another hospital in Trabzon. The 5-day-old neonate was transferred to our NICU because of neonatal convulsion and generalized hypotonia for further management. On the 7 th day of admission, S marcescens was grown in a blood culture. Within a week, microbiological samples yielded S marcescens from two more neonates in the NICU. The neonates infected with S marcescens were treated with antibiotic regimens, including meropenem (60 mg/kg per day divided into 3 doses) and amikacin (15 mg/kg per day divided into 2 doses).
Bacterial isolates
Serratia marcescens was isolated from clinical specimens using routine bacteriological procedures. All clinical samples except blood were inoculated onto trypticase soy agar with 5% sheep's blood (Becton Dickinson Bioscience, Sparks, MD, USA) and eosin methylene blue agar (Hi -Media Laboratories, Mumbai, India) plates, whereas the blood samples were inoculated first into an aerobic BACTEC 9240 Peds Plus bottle (Becton Dickinson Bioscience). Specimens for surveillance cultures from hospitalized neonates were obtained as described. 5 Eighty-five environmental and infant formula samples (using swabs and direct culturing of fluids) were taken from incubators, humidifiers, antiseptics, soaps, and sinks, in an attempt to identify any possible source of infection. Thirty-eight hand cultures were taken from health care workers (HCWs) by a standard broth bag technique. 6 All the samples were incubated overnight in brain heart infusion broth at 37 C and subcultured on eosin methylene blue agar. Additionally, two breast milk samples were also taken from two mothers.
The isolates from clinical or screening specimens were identified by standard laboratory methods, including the Phoenix automatic system for the identification and susceptibility testing (Becton Dickinson Bioscience). Antimicrobial susceptibility tests were performed using the NMIC/ID-55 panels of the Phoenix automatic system, according to the manufacturer's instructions, and the results were interpreted according to the breakpoints established by the Clinical and Laboratory Standards Institute. 7 The antimicrobial agents included were amoxicillin/clavulanate, ampicillin, ampicillin/sulbactam, aztreonam, cefazolin, cefepime, cefotaxime, ceftazidime, chloramphenicol, ciprofloxacin, amikacin, gentamicin, imipenem, levofloxacin, meropenem, piperacillin, piperacillin/tazobactam, tetracycline, and trimethoprim/sulphamethoxazole. Extended spectrum betalactamase (ESBL) production was initially screened by Phoenix automatic system. ESBL production was also investigated by a double-disk test. The isolates were stored at À70
C for further studies.
Pulsed-field gel electrophoresis typing
Molecular typing with pulse-field gel electrophoresis (PFGE) was used to compare 13 S marcescens isolates, including the samples from 10 patients, one hand wash sample, and two breast milk samples. Of the 10 isolates, four were derived from urine, three from blood, three from tracheal aspirates, and one from an abscess. For PFGE analysis, bacterial DNA was prepared as previously described with some modifications. 8, 9 Chromosomal DNA was digested using 30 U per sample SpeI (Promega Corp., Madison, WI, USA). Lambda phage concatemers (Bio-Rad Laboratories, Richmond, CA, USA) were run simultaneously as a size marker. The electrophoresis conditions using the CHEF-DR III system (Bio-Rad) had an initial switch time of 5 seconds and final switch time of 20 seconds (gradient of 6 V/cm and an included angle of 120 ) for a 20-hour run. The gels were stained for 20 minutes with ethidium bromide and destained in distilled water for 45 minutes. The results were analyzed with a Bio-Rad Gel Doc System (Bio-Rad) and Molecular Analyst Software (Bio-Rad). The genotypes were defined on the basis of DNA banding patterns as described elsewehere. 10 Isolates with identical patterns were considered genetically "indistinguishable", whereas those that differed by one to three bands were defined as "closely related", four to six bands as "possibly related", and greater than or equal to seven bands as "unrelated".
Results
The epidemiological data, antimicrobial profiles, and the PFGE patterns, corresponding to all isolates, are summarized in Tables 1 and 2 PFGE with SpeI yielded 16 or more visible bands for each isolate. They were sufficiently distinct to allow the division of the strains into three patterns (A, B, and C) with two subtypes (A1and A2) (Fig. 1) . Genomic typing identified one major pattern, PFGE-designated Pattern A (Patients 1, 2, 4 , 5, 8, and 10) shared by 6 of the 10 neonates, suggesting some cross-transmission of this bacterial strain between patients in the NICU. The PFGE patterns of isolates from Patients 6 and 7 showed a one-fragment difference. Hence, they were considered closely related (Pattern A1). The isolates from the other two neonates were genetically distinct. Two of the isolates from breast milk were indistinguishable with PFGE Pattern A. The isolate obtained from one hand-washing sample was unrelated to the outbreak strain, which differed by seven bands (Pattern D). With the exception of Clone D, all isolates belonging to Clones A, A1, B, and C, were susceptible to trimethoprim/ sulfamethoxazole, amikacin, imipenem, meropenem, and ciprofloxacin, whereas susceptibility to aztreonam, cefepime, and piperacillin/tazobactam, varied among strains. The Clone D strain was susceptible to cefotaxime, ceftazidime, and gentamicin. No correlation was found between PFGE and antibiotic patterns.
The outbreak was stopped by reinforcing standard infection control procedures, including hand washing, cohorting infected/colonized neonates, and disinfecting environmental surfaces. No other infections by S marcescens were diagnosed, and the colonization rate returned to the pre-epidemic value in another 12 months of follow-up in the NICU.
Discussion
Serratia marcescens is a well-known causative agent of hospital infections and can be the source of epidemic outbreak in NICU. 9 Recently, there have been several reports of S marcescens outbreaks in NICUs 3,9,11e15 where the newborns known to be immature in the sense of proper immune response are taken care of for various health problems. The environmental surfaces, invasive medical devices, intravenous and topical solutions, or soap may seem to be the pathogen's source, 12, 16, 17 whereas the hands of HCWs can serve as an important source of infection. 1 Colonization rates of S marcescens on the hands of HCWs have been described to range from 15.4% to 24%. 17 However, it has been reported that infected or colonized neonates are the primary source in most S marcescens outbreaks.
11
14 In our study, environmental cultures from NICU were all negative for S marcescens. Our intensive efforts failed to determine the source of the outbreak despite the finding that S marcescens strain was isolated from an HCW's hand. The bacterial isolate obtained from the staff member was determined by PFGE to be unrelated to the outbreak strain, which differed by seven bands. Despite our negative results, we believe that cross-transmission through transient contamination of hands played a major role in this outbreak. Because breast milk has also been suggested to be a source of infection, 18 we also tested the breast milk samples of the mothers of Patients 2 and 5 and detected S marcescens. The contaminated breast milk in our case could be implicated as a source of infection in two neonates, but we were unable to conclude definitely whether it is the case because no milk samples could be taken from their mothers before the infection.
The PFGE patterns of isolates from Patients 3 and 9 were genetically distinct from that of the outbreak-causing strain. These neonates were transferred from another hospital to our NICU, and infections occurred before or within 48 hours of admission to our NICU, suggesting that they had acquired the infection from the hospital where they were first admitted.
Outbreaks of S marcescens have been reported to spread very rapidly with significant morbidity and mortality. 9, 12, 14 Therefore, the rapid typing methods are essential in terms of prompt and sensitive evaluation of S marcescens outbreaks in hospitals and, thus, implementing effective preventive measures when the sources are identified. 15 A number of epidemiological typing methods, including antibiotyping, serotyping, phage typing, plasmid typing, polymerase chain reactionebased typing, and analysis of genomic DNA by PFGE have been described. Antibiograms present little value in most epidemiological studies because isolates with unrelated genetic and epidemiological features have been shown to present the same susceptibility pattern because of the acquisition of the same plasmid by multiple species, named as plasmid outbreak. 19 In the present study, the antibiograms revealed quite variable results as compared with those of PFGE typing, and unrelated isolates had similar antibiotypes. PFGE is the method of choice for outbreaks of S marcescens, 3, 12 and particularly, the method used in this study is considerably rapid, taking about 28 hours to complete, to allow prompt acting in the case of an outbreak and to implement effective preventive measures. Although the source of the outbreak could not be definitely identified in the present study, it was concluded that the successful growth of S marcescens from the hand samples of one HCW may indicate that transient contamination from working staff may be more important than environmental contamination. One of the interesting findings in our study was to be able to grow S marcescens from a breast milk sample, suggesting that contamination from mother's milk could be possible with a caveat that no correlation can be established regarding contamination among patients. The PFGE protocol used in this study is a simple, highly discriminatory, and cost-effective method for the thorough epidemiological investigation of an outbreak of S marcescens.
